Back to GALE Stock Lookup
Pages: 1 2 »» Last Page

Galena Biopharma (GALE) – Press Releases

Dec 11, 2014 08:35 AM Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Sympo
Dec 8, 2014 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 8, 2014 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 5, 2014 07:05 AM Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)
Dec 5, 2014 07:05 AM Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)
Dec 2, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of U.S. Patent Application for GALE-401 (Anagrelide Controlled Release) Composition of Matter
Dec 2, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of U.S. Patent Application for GALE-401 (Anagrelide Controlled Release) Composition of Matter
Dec 1, 2014 07:05 AM Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 1 Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 1, 2014 07:05 AM Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 1 Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Nov 25, 2014 07:05 AM Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare Conference
Nov 25, 2014 07:05 AM Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare Conference
Nov 20, 2014 04:20 PM Galena Biopharma Announces Purchase Agreement for Up to $55.0 Million With Lincoln Park Capital Fund, LLC
Nov 20, 2014 04:20 PM Galena Biopharma Announces Purchase Agreement for Up to $55.0 Million With Lincoln Park Capital Fund, LLC
Nov 18, 2014 07:05 AM Galena Biopharma Completes Enrollment in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Nov 18, 2014 07:05 AM Galena Biopharma Completes Enrollment in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Nov 13, 2014 07:05 AM Galena Biopharma to Present at the Stifel 2014 Healthcare Conference
Nov 13, 2014 07:05 AM Galena Biopharma to Present at the Stifel 2014 Healthcare Conference
Nov 11, 2014 07:05 AM Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast C
Nov 11, 2014 07:05 AM Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast C
Nov 7, 2014 07:05 AM Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting
Nov 7, 2014 07:05 AM Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting
Nov 4, 2014 07:05 AM Galena Biopharma to Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data at the Society for the Immunotherapy of Cancer (SITC) 29th Annual Meeting on Friday, November 7, 2014
Nov 4, 2014 07:05 AM Galena Biopharma to Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data at the Society for the Immunotherapy of Cancer (SITC) 29th Annual Meeting on Friday, November 7, 2014
Nov 3, 2014 04:20 PM Galena Biopharma Reports Third Quarter 2014 Results
Oct 27, 2014 07:05 AM Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014
Oct 27, 2014 07:05 AM Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014
Oct 14, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan
Oct 14, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan
Oct 8, 2014 07:05 AM Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination
Oct 8, 2014 07:05 AM Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination
Sep 25, 2014 04:15 PM Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update
Sep 25, 2014 04:15 PM Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update
Sep 9, 2014 07:05 AM Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Sep 3, 2014 07:05 AM Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Aug 21, 2014 07:05 AM Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Aug 11, 2014 04:35 PM Galena Biopharma Reports Second Quarter 2014 Results
Jul 29, 2014 07:05 AM Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014
Jul 22, 2014 07:05 AM Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film
Jul 1, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S)
Jun 19, 2014 07:05 AM Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 17, 2014 07:05 AM Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers
Jun 2, 2014 07:05 AM Galena Biopharma Presents GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting
May 30, 2014 07:05 AM Galena Biopharma to Present at the Jefferies 2014 Global Healthcare Conference
May 21, 2014 07:05 AM Galena Biopharma to Present GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting
Apr 30, 2014 07:05 AM Galena Biopharma to Present at the 39th Annual Deutsche Bank Health Care Conference
Apr 28, 2014 07:05 AM Galena Biopharma Announces Department of Defense Grant for NeuVax(TM) (nelipepimut-S) Clinical Trial
Apr 25, 2014 07:05 AM Galena Biopharma to Report First Quarter 2014 Financial Results on Tuesday, May 6, 2014
Apr 24, 2014 07:05 AM Galena Biopharma Research Pioneer Presented With 2014 Award for Excellence in Technology Transfer
Apr 3, 2014 07:05 AM Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference
Mar 20, 2014 07:05 AM Galena Biopharma Participates in Two Upcoming Conferences
Pages: 1 2 »» Last Page

Back to GALE Stock Lookup